ArticlePDF Available

The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls

Authors:

Abstract and Figures

The Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-cog) is commonly used to assess cognitive dysfunction in individuals with Alzheimer disease and other dementias. The purpose of this study was to provide normative scores for the ADAS-cog 11 individual items and total score, as well for delayed recall errors, using normal, elderly volunteers. The ADAS-cog was administered to 124, non-cognitively impaired volunteers ages 55 to 89, with 10 to 21 years of education. The mean total ADAS-cog score was five. The ADAS-cog error score was not associated with education in this highly educated group, and was positively correlated (P < 0.001) with the age of the participant. Age stratified ADAS-cog normative data are reported for the ADAS-cog total and the delayed recall error score.
Content may be subject to copyright.
ORIGINAL ARTICLE
The Alzheimer’s Disease Assessment
Scale - Cognitive Subscale
Normative Data for Older Adult Controls
David P. Graham, MD,*†
k
Jeffrey A. Cully, PhD,*†
k
A. Lynn Snow, PhD,*†
k
Paul Massman, PhD,{# and Rachelle Doody, MD, PhD§#
Abstract: The Alzheimer’s Disease Assessment Scale - Cognitive
subscale (ADAS-cog) is commonly used to assess cognitive dysfunc-
tion in individuals with Alzheimer disease and other dementias. The
purpose of this study was to provide normative scores for the ADAS-
cog 11 individual items and total score, as well for delayed recall
errors, using normal, elderly volunteers. The ADAS-cog was admin-
istered to 124, non-cognitively impaired volunteers ages 55 to 89,
with 10 to 21 years of education. The mean total ADAS-cog score
was five. The ADAS-cog error score was not associated with educa-
tion in this highly educated group, and was positively correlated (P ,
0.001) with the age of the participant. Age stratified ADAS-cog
normative data are reported for the ADAS-cog total and the delayed
recall error score.
Key Words: Alzheimer disease, assessment, dementia
(Alzheimer Dis Assoc Disord 2004;18:236–240)
T
he Alzheimer’s Disease Assessment Scale-cognitive sub-
scale (ADAS-cog) is commonly used to assess cognitive
dysfunction in individuals with Alzheimer disease.
1
The
ADAS-cog is a reliable and valid instrument
1,2
that has become
a standard outcome measure in multi-national Alzheimer dis-
ease treatment trials, and is widely used in studies as diverse as
caregiver burden,
3
functional status,
4
and staging of Alzheimer
disease.
5
As a testament to the widespread use of the ADAS-
cog, the reliability and validity of the ADAS-cog have been
confirmed by a number of studies in a variety of languages.
6–10
While not a substitute for extensive neuropsychological
assessment, the ADAS-cog is considered more complete than
most other cognitive screening measures.
11
The ADAS-cog scale (total score range from 0 to 70)
assesses performance on eleven cognitive tasks: orientation,
three trials of a 10-word list learning task (average score), three
trials of a 12 word recognition task (average score), recall of
instructions, comprehension of commands, object and finger
naming, word finding difficulty, expressive language, lan-
guage comprehension, ideational praxis, and constructional
praxis. A frequently used modification of the scale includes
a five minute delayed recall trial for the 10-word list.
Studies have shown that several sociodemographic
variables may influence ADAS-cog performance. Lower levels
of education may affect ADAS-cog scores.
7,12
Results for
highly educated individuals with dementia may overlap with
minimally educated, non-demented individuals,
13
particularly
those with less than seven years of schooling,
10
resulting in
a higher risk of false positives.
14
The ADAS-cog may be influ-
enced by age (younger age associated with modestly superior
performance),
15–17
and gender (male gender associated with
modestly superior performance).
18
Despite the frequency of research and clinical trials
using the ADAS-cog, only four studies reference ADAS-cog
normative data for Alzheimer disease and mild cognitive
impairment (MCI) patient populations,
19,20
and elderly
controls.
15,21
Additionally, only two studies describe individual
item performance in normal subjects.
20,21
Schmeidler’s study
reported values for various severity strata of Alzheimer disease
patients, but not for normal controls. Grundman’s study
reported numerical values for only four of the ADAS-cog
items. Although Zec et al presented ADAS-cog total error data
for stratified ages 7 to 80+,
15
the study did not provide specific
normative data (e.g. means and standard deviations for the
eleven individual tasks).
21
A recent study of MCI patients
indicated that the ADAS-cog may be a useful measure in
treatment models for patients with this condition,
22
however,
adequate normative data is needed to separate normal control
subjects from those with MCI.
The purpose of the present study was to evaluate the
ADAS-cog, including delayed recall, controlling for the effects
of age, gender, and educational level in normal controls. We
offer an age-stratified normative reference base for score
interpretation and comparison of the ADAS-cog for normal
controls.
METHODS
Subjects: This study used data from 124 non-demented,
non-MCI, non-depressed, older adult volunteers recruited to
a prospective longitudinal study at the Baylor College of
Medicine (BCM) Alzheimer’s Disease Center (ADC). The
Received for publication April 21, 2004; accepted September 30, 2004.
From the *Veterans Affairs South Central Mental Illness Research, Education,
and Clinical Center (MIRECC), Psychiatry and Behavioral Sciences,
Medicine, and §Neurology Departments, Baylor College of Medicine,
k
Houston Center for Quality of Care and Utilization Studies, Health
Services Research & Development, Michael E. Debakey Veterans Affairs
Medical Center, {Department of Psychology, University of Houston,
#Baylor College of Medicine Alzheimer’s Disease Center.
Reprints: David P. Graham, MD, Michael E. DeBakey Veterans Affairs
Medical Center, 2002 Holcombe Blvd. (152), Houston, Texas 77030
(e-mail: david.graham@med.va.gov).
Copyright Ó 2004 by Lippincott Williams & Wilkins
236 Alzheimer Dis Assoc Disord
Volume 18, Number 4, October–December 2004
JOBNAME: alz 18#4 2004 PAGE: 1 OUTPUT: Mon November 29 12:09:45 2004
lww/alz/88441/04-032
normal controls were recruited, after BCM IRB approval, from
a registry of normal senior volunteers or from community
volunteers.
Initial evaluations included a clinical interview and
assessment of cognitive abilities, including the ADAS-cog and
the Mini-Mental State Examination.
23
The authors also
assessed delayed recall of the ADAS-cog 10-item word list
after a delay of five minutes as part of the memory testing.
Additionally, a neurologic examination, a health-screening
questionnaire, and an extensive neuropsychological assess-
ment battery were included in the initial evaluation to confirm
‘normal control’status. All subjects were required to perform
in the normal range on neuropsychological testing which was
objectified as not scoring below the 5th percentile on more
than two measures. All subjects scored 26 or better on the
MMSE.
Procedures
An independent sample t test was used to evaluate
whether ADAS-cog scores differed between men and women.
Pearson correlations were used to evaluate whether age, years
of education, and MMSE scores were related to the ADAS-cog
total score and each of 11 individual ADAS-cog item scores
and the delayed recall error score. An ANOVA with Games-
Howell procedure for multiple comparisons with unequal
variance and/or unequal group sample sizes was used to
examine the effects of age cohorts on the ADAS-cog total
score. The age cohorts constructed included: 55 to 64, 65 to
69, 70 to 74, 75 to 79, and 80 to 89 years of age. The Kruskal-
Wallis test was used to examine the relationship between the
ADAS-cog and education categorized into three groups: high
school, college, and post-Baccalaureate. Bonferonni adjust-
ments were used to prevent capitalization on chance (ADAS-
cog evaluation 48 tests, a = 0.001; covariate analysis 6 tests,
a = 0.008, age-stratified analysis 5 tests, a = 0.01). Statistical
analyses were performed using SPSS for Windows version
11.5.0.
24
To evaluate the limitations of our single-ethnicity
sample, post-hoc comparisons of the mean ADAS-cog total
score and years of education were made between our results,
and the results of Liu et al
10
and Grundman et al
20
using a two
sample independent t test with Satterthwaite’s approximation
for unequal variances using Stata version 8.2.
25
Liu et al’s
study was comprised of one ethnicity (Chinese), while
Grundman et al’s control group was 71% Caucasian, 14%
African American, 10% Hispanic, 3% Asian American, 1%
American Indian, and 1% ‘Other.
RESULTS
The mean age of the124 participants in the study was
71.2 years (SD = 5.89, range 55 to 89). There were 65 men
(52.4%) and 59 women (47.6%), and all were Caucasian. They
had a mean of 15.6 total years of education (SD = 2.21).
Fourteen (11.3%) had some high school education (10 to 12
years), 72 (58.1%) had some college education (13 to 16
years), and 38 (30.6%) had some post-Baccalaureate education
(16 to 21years). ADAS-cog and MMSE scores for the sample
of 124 participants are summarized in Table 1. The majority of
errors on the ADAS-cog were made on word recall and word
recognition tasks and the median error score for the nine other
items was zero, with a range of zero to two. Men and women
did not differ on the total ADAS-cog score (t = 1.32, two-tailed
P $ 0.19, 95% CI = -0.27 to 1.33). ADAS-cog scores were not
significantly correlated with years of education (r = 0.04, P .
0.65). Results were the same when education was examined
categorically; neither having some college education or some
post-baccalaureate education affected the ADAS-cog score
compared with some high-school education (x
2
(2) = 0.089,
TABLE 1. Normative Scores for the ADAS-cog Individual Items and Total Score,
Delayed Recall Item Score, and MMSE Score
Median Mode Mean S.D. 95% C.I. Range
ADAS-cog total error score 5 5 4.98 2.25 4.58 to 5.38 1–11
Memory Components
Word Recall 3 3 3.19 1.33 3.19 to 3.42 1–6
Word Recognition 1 1 1.17 1.17 .97 to 1.38 0–7
Remembering Instructions 0000 0to0 0
Orientation 0 0 .10 .31 .05 to .16 0–1
Language Components
Naming (fingers & objects) 0 0 .05 .22 .01 to .09 0–1
Word Finding Difficulty 0 0 .01 .09 2.01 to .02 0–1
Follow oral commands 0 0 .11 .34 .05 to .17 0–2
Expressive Language 0 0 .02 .15 .00 to .05 0–1
Comprehension 0 0 .03 .22 2.01 to .07 0–2
Praxis Components
Constructional Praxis 0 0 .30 .49 .21 to .39 0–2
Ideational Praxis 0 0 .00 .00 0 to 0 0
Delayed Recall error score 4 5 3.82 2.12 3.45 to 4.20 0–10
MMSE total score 29 30 29.29 .85 29.14 to 29.44 26–30
ADAS-cog, Alzheimer’s Disease Assessment Scale - Cognitive subscale; MMSE, Mini-Mental State Examination.
q 2004 Lippincott Williams & Wilkins 237
Alzheimer Dis Assoc Disord
Volume 18, Number 4, October–December 2004 The Alzheimer’s Disease Assessment Scale
JOBNAME: alz 18#4 2004 PAGE: 2 OUTPUT: Mon November 29 12:09:46 2004
lww/alz/88441/04-032
P . 0.95). Years of education were not significantly correlated
with either age (all age strata had between a mean of 15.27 to
16.00 years of education) or the MMSE total score.
ADAS-cog scores were correlated significantly with age
(r = 0.34, P , 0.001). When divided into age strata, the effect
remained (one-way ANOVA (d.f. 4, 123), F = 3.767, P =
0.006). The results summary for the ADAS-cog total score by
age strata is presented in Table 2. Age was also positively
correlated with the individual ADAS-cog item of word recall
(r = 0.30, P = 0.001), but not with any other ADAS-cog items.
A trend toward statistical significance (P = 0.002, just above
Bonferroni correction of P = 0.001) was exhibited by two
ADAS-cog items: word finding (r = 0.27) and expressive lan-
guage (r = 0.28); as well as the additional task of delayed recall
errors (r = 0.28, P = 0.002).
The ADAS-cog error scores were inversely, but non-
significantly, related to the MMSE scores (Pearson r = 20.13,
P = 0.157), and were positively correlated to the individual
items: word recall (r = 0.75, P , 0.001), word recognition (r =
0.68, P , 0.001), constructional praxis (r = 0.31, P , 0.001),
follow commands (r = 0.31, P , 0.001), and the naming score
(r = 0.31, P , 0.001). The total ADAS-cog error score was
positively correlated with the delayed recall error score (r =
0.56, P , 0.001). Age, years of education, and the total MMSE
score were not significantly correlated (r values all , 0.12, all
P values . 0.20).
DISCUSSION
The main purpose of this study is to report preliminary
age-stratified normative control data for the Alzheimer Disease
Assessment Scale - Cognitive subscale total score and scores
for each of eleven individual components as well as for
delayed recall. Although controls, on average, score about five
errors on the ADAS-cog, those under age 70 are more likely to
score four errors, while those 70 to 79 will score a median of
five errors, and those 80 and over normally score a median of
eight errors. With respect to delayed recall errors, the data
show those under age 65 scored a median of two errors, while
those over age 65 typically scored a median of four errors. Our
average delayed recall error score was probably higher than
that of Grundman et al
20
because his normal control subjects
were selected, in part, on the basis of paragraph recall
performance, and we had no such a priori restriction. These
data are important because the ADAS-cog has become
a standard measure in clinical trials involving Alzheimer
disease patients,
26
and may become a standard in MCI trials,
where separation of normal from MCI subjects is critical.
Our study found an influence of age on the ADAS-
cog total error scores, supporting the views of Zec et al,
15
Doraiswamy et al,
16
and Pena-Casanova et al,
17
, particularly
over age 80. This positive correlation was seen whether age
was viewed as a continuous variable or grouped into cohorts.
The age of the patients in our study was similar to that of Liu
et al and Grudman et al (mean of 72.7 years versus 71.2 versus
70.0 years) and gender composition was also similar (52%
male versus 52% male versus 40% male). Our study supports
reports that gender has no apparent effect on the total ADAS-
cog score, contrasting with Doraiswamy et al.
18
Although the mean ADAS-cog total scores were not
statistically different, the education in our populations did
differ significantly; our study population had a mean of 15.6
years of education, Liu et al had a mean of 9.9 years, and
Grundman et al had a mean education of 14.8 years. Liu et al
10
found that there may be an influence of very low education
levels (zero to six years). Since we found no influence of
ten years or more of education, it could be that a threshold
level of education between seven and ten years is required to
TABLE 2. Descriptive Statistics for Total ADAS-cog Error Score, Delayed Recall Error Score, and Years of Education
by Age Cohort
Median Mode Mean S.D. Z-score 95% C.I. Range
n = 124 ADAS-cog total score 5 5 4.98 2.25 4.58 to 5.38 1–11
n=15 Ages 55 to 64 4 4 3.60 1.64 2.61 2.69 to 4.51 1–6
n=30 Ages 65 to 69 4 4 4.51 2.18 2.21 3.70 to 5.32 1–10
n=48 Ages 70 to 74 5 5 5.13 2.06 .07 4.53 to 5.72 1–9
n=20 Ages 75 to 79 5 5 5.51 2.11 .24 4.53 to 6.50 2–11
n=11 Ages 80 to 89 8 8 6.57 3.02 .71 4.55 to 8.60 2–11
n = 124 Delayed recall error score 4 5 3.82 2.12 3.45 to 4.20 0–10
n=15 Ages 55 to 64 2 1 2.73 2.19 2.51 1.52 to 3.94 0–7
n=30 Ages 65 to 69 3.5 5 3.33 1.94 2.23 2.61 to 4.06 0–6
n=48 Ages 70 to 74 4 5 3.92 1.97 .05 3.35 to 4.49 0–9
n=20 Ages 75 to 79 4.5 4 & 5 4.60 2.19 .37 3.58 to 5.62 1–10
n=11 Ages 80 to 89 4 4 4.82 2.40 .47 3.21 to 6.43 1–9
n = 124 Years of Education 16 16 15.56 2.21 15.17 to 15.96 10–21
n=15 Ages 55 to 64 15 14 15.27 2.55 13.86 to 16.68 10–20
n=30 Ages 65 to 69 16 16 15.60 1.94 14.88 to 16.32 12–20
n=48 Ages 70 to 74 16 16 15.65 2.05 15.05 to 16.24 12–21
n=20 Ages 75 to 79 15.5 14 & 16 15.30 2.76 14.01 to 16.59 11–20
n=11 Ages 80 to 89 16 16 16.00 2.32 14.44 to 17.56 12–20
ADAS-cog, Alzheimer’s Disease Assessment Scale - Cognitive subscale.
238 q 2004 Lippincott Williams & Wilkins
Graham et al Alzheimer Dis Assoc Disord
Volume 18, Number 4, October–December 2004
JOBNAME: alz 18#4 2004 PAGE: 3 OUTPUT: Mon November 29 12:09:48 2004
lww/alz/88441/04-032
successfully evaluate ADAS-cog performance. This would be
consistent with the conclusions from Doraiswamy et al,
12
who
stated that worse performance was seen in subjects with less
than a high school education; as well as with Zec et al,
15
who
stated that higher ADAS-cog error scores were seen in subjects
ages seven to thirteen (who generally should have less than
eight years of education). Our data cannot be used to deter-
mine whether low education has a negative effect, or whether
meeting a particular threshold of education lends a positive
effect.
We found a mean total ADAS-cog value of 5.0, identical
to the mean of 5.0 found by Liu et al,
10
and very similar to the
mean of 5.5 found by Zec et al,
15
and 5.6 by Grundman et al.
20
All of these scores are lower than the mean scores reported for
demented individuals.
10,16,19,20
Further, it is important to note
the mean ADAS-cog total scores are not statistically different
despite the different ethnicities comprising the studies. This
study was comprised of no minorities, Liu et al
10
evaluated
a 100% Chinese population, and Grundman et al
20
used a popu-
lation in which 20% of the control sample was of minority
status. These similarities in mean scores across samples and
ethnicities suggests ethnicity may not be an important deter-
minant of ADAS-cog scores. Caution should be applied to
comparisons between studies regarding different ethnicities, as
subtle differences in testing procedures may have an un-
recognized affect on ADAS-cog total or component scores. An
example is the study by Liu et al,
10
who attempted to accom-
modate illiteracy in subjects by including pictorial versus
verbal stimuli in their testing methodology.
In summary, our study reports new preliminary data on
expected performance of normal controls on the ADAS-cog,
and gives actual expected age-adjusted norms. Several limita-
tions affect generalizability: First, our population consisted of
one ethnicity, Caucasian, but our mean scores do not differ
from studies performed with other ethnicities. Second, our
population consisted of a highly educated group, restricting us
from examining the possible influences of very low education
on the ADAS-cog. Third, our sample size was not matched
across age stratification. Despite these limitations, and given
the widespread use of the ADAS-cog, the reported preliminary
normative data generated by this study provide a useful refer-
ence for clinicians and researchers, especially those attempting
to differentiate between normal and atypical cognitive func-
tioning in older adults.
More normative studies are clearly needed to enhance
our understanding of the interactions among the various points
including age, education and ethnicity. Furthermore, we recom-
mend future studies seriously consider the inclusion of larger
sample sizes, both age and education stratification, better repre-
sentation of minorities, and better representation of low edu-
cational levels in their design.
ACKNOWLEDGMENTS
This work was supported by NIH AGO P50 8664 (P.M.
and R.D.) as well as by a Zenith Award from the Alzheimer’s
Association (R.D.). Additionally, this material is based in part
upon work supported by the Office of Academic Affiliations, VA
Special MIRECC Fellowship Program in Advanced Psychiatry
and Psychology, Department of Veteran Affairs (D.G.), and the
Health Services Research and Development Service, Office of
Research and Development, Department of Veterans Affairs
(RCD 01-008-1).
REFERENCES
1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s
disease. Am J Psychiatry. 1984;141:1356–1364.
2. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of
Alzheimer’s disease: measurement, rate, and predictors of cognitive dete-
rioration. Am J Psychiatry. 1994;151:390–396.
3. Caro J, Ward A, Ishak K, et al. To what degree does cognitive impairment
in Alzheimer’s disease predict dependence of patients on caregivers? BMC
Neurol. 2002;2:6.
4. Farias ST, Harrell E, Neumann C, et al. The relationship between
neuropsychological performance and daily functioning in individuals with
Alzheimer’s disease: ecological validity of neuropsychological tests. Arch
Clin Neuropsychol. 2003;18:655–672.
5. Hannesdottir K, Snaedal J. A study of the Alzheimer’s Disease Assess-
ment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
Nord J Psychiatry. 2002;56:201–206.
6. Tsolaki M, Fountoulakis K, Nakopoulou E, et al. Alzheimer’s disease
assessment scale: the validation of the scale in Greece in elderly demented
patients and normal subjects. Dement Geriatr Cogn Disord. 1997;8:273–
280.
7. Weyer G, Erzigkeit H, Kanowski S, et al. Alzheimer’s disease assess-
ment scale: Reliability and validity in a multicenter clinical trial. Int
Psychogeriatr. 1997;9:123–138.
8. Inzitari D, Rossi R, Lamassa M, et al. Validity of different linguistic
versions of the Alzheimer’s disease assessment scale in an international
multicentre Alzheimer’s disease trial. Dement Geriatr Cogn Disord. 1999;
10:269–277.
9. Chu LW, Chiu KC, Hui SL, et al. The reliability and validity of the
Alzheimer’s disease assessment scale cognitive subscale (ADAS-cog)
among the elderly Chinese in Hong Kong. Ann Acad Med Singapore.
2000;29:474–485.
10. Liu HC, Teng EL, Chuang YY, et al. The Alzheimer’s disease assessment
scale: findings from a low-education population. Dement Geriatr Cogn
Disord. 2002;13:21–26.
11. Pena-Casanova J, Aguilar M, Santacruz P, et al. Adaptation and
normalization of the Alzheimer’s disease Assessment Scale for Spain
(NORMACODEM) (II). Neurologia. 1997;12:69–77.
12. Doraiswamy PM, Krishen A, Stallone F, et al. Cognitive performance of
the Alzheimer’s disease assessment scale: effect of education. Neurology.
1995;25:1980–1984.
13. Schultz RR, Siviero MO, Bertolucci PH. The cognitive subscale of the
Alzheimer’s disease assessment scale’ in a Brazilian sample. Braz J Med
Biol Res. 2001;34:1295–1302.
14. Kolibas E, Korinkova V, Novotny V, et al. ADAS-cog (Alzheimer’s
Disease Assessment Scale - cognitive subscale) - validation of the Slovak
version. Bratisl Lek Listy. 2000;101:598–602.
15. Zec RF, Landreth ES, Vicari SK, et al. Alzheimer disease assessment
scale: useful for both early detection and staging of dementia of the
Alzheimer type. Alzheimer Dis Assoc Disord. 1992a;6:89–102.
16. Doraiswamy PM, Bieber F, Kaiser L, et al. The Alzheimer’s Disease
Assessment Scale: patterns and predictors of baseline cognitive perfor-
mance in multicenter Alzheimer’s disease trials. Neurology. 1997a;48:
1511–1517.
17. Pena-Casanova J. Alzheimer’s Disease Assessment Scale–cognitive in
clinical practice. Int Psychogeriatr. 1997;9:105–114.
18. Doraiswamy PM, Bieber F, Kaiser L, et al. Memory, language, and praxis
in Alzheimer’s disease: norms for outpatient clinical trial populations.
Psychopharmacol Bull. 1997b;33:123–128.
19. Schmeidler R, Mohs RC, Aryan M. Relationship of disease severity to
decline on specific cognitive and functional measures in Alzheimer
disease. Alzheimer Dis Assoc Disord. 1998;12:146–151.
20. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment
can be distinguished from Alzheimer disease and normal aging for clinical
trials. Arch Neurol. 2004;61:59–66.
q 2004 Lippincott Williams & Wilkins 239
Alzheimer Dis Assoc Disord
Volume 18, Number 4, October–December 2004 The Alzheimer’s Disease Assessment Scale
JOBNAME: alz 18#4 2004 PAGE: 4 OUTPUT: Mon November 29 12:09:48 2004
lww/alz/88441/04-032
21. Zec RF, Landreth ES, Vicari SK, et al. Alzheimer Disease Assessment
Scale: a subtest analysis. Alzheimer Dis Assoc Disord. 1992b;6:164–181.
22. Salloway SP, Kumar D, Ieni J, et al. Benefits of Donepezil treatment in pa-
tients with Mild Cognitive Impairment. Neurology. 2003;60(Suppl 1):A411.
23. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State Examination.
J Psychiatr Res. 1975;2:189–198.
24. SPSS for Windows version 11.5.0. SPSS Inc. Headquarters, 233 S.
Wacker Drive, 11th floor Chicago, Illinois 60606. Copyright 1989 - 2002.
http://www.spss.com.
25. Stata version 8.2. StataCorp, 4905 Lakeway Drive, College Station, Texas
77845 USA. Copyright 1984 2003: http://www.stata.com.
26. Gillen TE, Gregg KM, Yuan H, et al. Clinical trials in Alzheimer’s disease.
Calculating Alzheimer’s Disease Assessment Scale-cognitive subsection
with the data from the consortium to establish a registry for Alzheimer’s
disease. Psychopharmacol Bull. 2001;35:83–96.
27. Weyer G, Ihl R, Schambach M. Alzheimer’s disease assessment scale
(ADAS). Deutschsprachige Bearbeitung. Dokumentationsbogen und
Testmaterial. Weinheim, Beltz, 1992.
240 q 2004 Lippincott Williams & Wilkins
Graham et al Alzheimer Dis Assoc Disord
Volume 18, Number 4, October–December 2004
JOBNAME: alz 18#4 2004 PAGE: 5 OUTPUT: Mon November 29 12:09:49 2004
lww/alz/88441/04-032
... This is probably the result of participants' differential socio-economic status, different educational levels as well as cross-cultural differences. A significant factor that could explain this controversy is the fact that we computed different cut-off scores for separate age groups and educational levels, because these variables strongly affect the ADAS-Cog-G sum scores, whereas other studies like the one from Graham et al. [62], did not stratify ADAS-Cog cut-off scores by educational level. Moreover, another reason that could probably explain the controversial results between our study to previous ones, is that in this study participants who had 11-12 years of schooling were considered the 'medium', whereas previous studies reported as mean score approximately the 15 years of schooling, which could probably explain better ADAS-Cog scores due to increased educational level. ...
... However, the control group of their study had lower educational level than AD participants. Furthermore, of foremost importance is that in previous studies like those from Ben Jemaa et al. [61], Graham et al. [62], and Kolibáš et al. [6], the ADAS-Cog sum score includes seven out of nine cognitive ADAS-Cog tasks, whereas the number cancellation as well as delayed recall subtasks are missing, plus the four non cognitive subtests which are the following; Spoken language ability, Comprehensive of spoken language, Commands, and Recall of test instructions. Additionally, studies like the one from Graham et al. [62] support that the delayed recall sub test should be assumed as a separate test from the sum of tests used to calculate the ADAS-Cog sum score. ...
... Furthermore, of foremost importance is that in previous studies like those from Ben Jemaa et al. [61], Graham et al. [62], and Kolibáš et al. [6], the ADAS-Cog sum score includes seven out of nine cognitive ADAS-Cog tasks, whereas the number cancellation as well as delayed recall subtasks are missing, plus the four non cognitive subtests which are the following; Spoken language ability, Comprehensive of spoken language, Commands, and Recall of test instructions. Additionally, studies like the one from Graham et al. [62] support that the delayed recall sub test should be assumed as a separate test from the sum of tests used to calculate the ADAS-Cog sum score. On the other hand, the total ADAS-Cog score in this study was calculated from the nine cognitive subtests, mentioned in the Methods section, which probably explains why our cut-off scores are increased compared to those studies. ...
Article
Full-text available
Background: Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) is a widely used screening tool for detecting older adults with Alzheimer’s disease among their cognitively healthy peers. A previous study in Greek population showed that ADAS-Cog-Greek (G) is a valid tool and can identify people with Alzheimer’s disease from older adult control group; however, there is no current data about whether ADAS-Cog can differentiate older adults with mild cognitive impairment (MCI) from those who have subjective cognitive decline (SCD). Objective: The current study aimed to examine the discriminant potential of ADAS-Cog-G in Greek older adults who meet the criteria for SCD or MCI. Methods: Four hundred eighty-two community-dwelling older adults, visitors of the Greek Alzheimer Association and Related Disorders, were enrolled in the current study. One hundred seventy-six of them met the criteria for SCD and three hundred six had MCI. Results: Path analysis applied to the data showed that age, as well as educational level affected ADAS-Cog-G performance. Results showed that the cut-off scores, which better discriminate people with SCD from MCI as well as their sensitivity and specificity values, were extracted in participants with high educational level (13 educational years<) and mainly under the age of 75 years. Conclusions: The current study provided evidence concerning the discriminant potential of ADAS-Cog-G to differentiate older adults with SCD from those with MCI in the Greek population, and therefore contributes to the relevant literature on the field.
... На першому етапі визначалися показники когнітивних скринінгових шкал: шкали оцінки психічного статусу (шкала MMSE) -ПІКП фіксувалися при значеннях шкали менше 24 балів [11], Монреальської шкали оцінки когнітивних функцій (шкала МоСА) -ПІКП діагностувалися при значеннях шкали менше 26 балів [12]. На другому етапі нами застосовува-лися спеціалізовані інструменти, що визначають окремі компоненти когнітивної сфери: 10-ти бальний тест малювання годинника (ТМГ) для оцінки візуально-просторової орієнтації, пам'яті і виконавчих функцій [13], тест «5 слів» з визначенням безпосереднього та відстроченого відтворень (для дослідження зорової пам'яті) [14], батарею тестів для оцінки лобної дисфункції (БТОЛД)для оцінки виконавчих функцій [15] та когнітивну субшкалу шкали оцінки хвороби Альцгеймера (шкала ADAS-cog) [16]. ...
Article
Full-text available
Introduction. Disturbances of cardiac rhythm and conduction are risk factors for cognitive impairments. Aim: to determine peculiarities of the cognitive status in patients with impaired heart rhythm and conduction during the recovery period after ischemic non-lacunar strokes. Material and methods. This study included 52 patients with atrial fibrillation, 18 patients with atrioventricular block 2-3 degrees, and 24 patients with sinus rhythm who had an ischemic non-lacunar stroke during the last 6 months. Cognitive status was measured using the MMSE, MoCA, ADAS-cog scales, the Clock Drawing Test, the “5 Words” test, and the frontal assessment battery. Results. According to the MoCA scale, patients with atrial fibrillation and atrioventricular block were significantly more often diagnosed with post-stroke cognitive impairments (71.2% and 77.8%, respectively) compared with patients having sinus rhythm (37.5%). Among patients with cognitive impairments by the MoCA scale, the presence of atrial fibrillation was associated with a significant decrease in MoCA scale scores, compared with sinus rhythm (18.0 (17.0-22.0) versus 22.0 (18.0-23.0)). In patients with sinus rhythm, the clock-drawing test had higher scores (8.0 (7.0-9.0)) compared to cases with atrial fibrillation (7.0 (5.8-8.0)). Patients with sinus rhythm had higher values of the frontal assessment battery (15.0 (14.0-15.0)) compared to atrial fibrillation (13.0 (12.0-14.0)) and atrioventricular blocks (14.0 (13.0- 15.0)). Conclusions. During the first 6 months after schemic non-lacunar strokes, patients with impaired heart rhythm and conduction demonstrated a significant prevalence of cognitive impairments by the MoCA scale and significantly worse scores of cognitive tests for executive functions.
... The raw scores for each of the above neuropsychological measures were z-scored according to normative values that were published for cognitively healthy individuals around the overall mean age across groups (Amariglio et al., 2012;Gale et al., 2007;Goldberg et al., 2010;Graham et al., 2004;Weintraub et al., 2018). Trail Making Test-A, Trail Making Test-B, ADAS-Cog Total, ADAS-Cog Recall, and ADAS-Cog Recognition scores were multiplied by -1 to ensure higher scores corresponded to better performance on all tests. ...
... The raw scores for each of the above neuropsychological measures were z-scored according to normative values that were published for cognitively healthy individuals around the overall mean age across groups (Amariglio et al., 2012;Gale et al., 2007;Goldberg et al., 2010;Graham et al., 2004;Weintraub et al., 2018). Trail Making Test-A, Trail Making Test-B, ADAS-Cog Total, ADAS-Cog Recall, and ADAS-Cog Recognition scores were multiplied by -1 to ensure higher scores corresponded to better performance on all tests. ...
Preprint
Full-text available
Electroencephalography (EEG) has shown potential for identifying early-stage biomarkers of neurocognitive dysfunction associated with dementia due to Alzheimer's disease (AD). A large body of evidence shows that, compared to healthy controls (HC), AD is associated with power increases in lower EEG frequencies (delta and theta) and decreases in higher frequencies (alpha and beta), together with slowing of the peak alpha frequency. However, the pathophysiological processes underlying these changes remain unclear. For instance, recent studies have shown that apparent shifts in EEG power from high to low frequencies can be driven either by frequency specific periodic power changes or rather by non-oscillatory (aperiodic) changes in the underlying 1/f slope of the power spectrum. Hence, to clarify the mechanism(s) underlying the EEG alterations associated with AD, it is necessary to account for both periodic and aperiodic characteristics of the EEG signal. Across two independent datasets, we examined whether resting-state EEG changes linked to AD reflect true oscillatory (periodic) changes, changes in the aperiodic (non-oscillatory) signal, or a combination of both. We found strong evidence that the alterations are purely periodic in nature, with decreases in oscillatory power at alpha and beta frequencies (AD < HC) leading to lower (alpha + beta) / (delta + theta) power ratios in AD. Aperiodic EEG features did not differ between AD and HC. By replicating the findings in two cohorts, we provide robust evidence for purely oscillatory pathophysiology in AD and against aperiodic EEG changes. We therefore clarify the alterations underlying the neural dynamics in AD and emphasise the robustness of oscillatory AD signatures, which may further be used as potential prognostic or interventional targets in future clinical investigations.
Chapter
Alzheimer’s disease (AD) is a neurodegenerative disease with unknown pathogenesis that manifests with a common type of dementia. With a persistent increase in the aging population worldwide, AD has become a public health concern. Early diagnosis of AD is challenging due to its insidious onset and irreversible progression. The analysis of multiple brain features combined with artificial intelligence has been widely used for the intelligent diagnosis (ID) of AD in recent years. This study aimed to comprehensively review the relevant studies on the ID of AD from the following five aspects: clinical scales, gene and cerebrospinal fluid, brain neuroimaging, text mining, and combined features, paving a path for developing the prospects of ID in AD.
Article
Adopting preventive strategies in individuals with subclinical Alzheimer's disease (AD) has the potential to delay dementia onset and reduce healthcare costs. Thus, it is extremely important to identify inexpensive, scalable, sensitive, and specific markers to track disease progression. The electroencephalography spectral power ratio (SPR: the fast to slow spectral power ratio), a measure of the shift in power distribution from higher to lower frequencies, holds potential for aiding clinical practice. The SPR is altered in patients with AD, correlates with cognitive functions, and can be easily implemented in clinical settings. However, whether the SPR is sensitive to pathophysiological changes in the prodromal stage of AD is unclear. We explored the SPR of individuals diagnosed with amyloid-positive amnestic mild cognitive impairment (Aβ+aMCI) and its association with both cognitive function and amyloid load. The SPR was lower in Aβ+aMCI than in the cognitively unimpaired individuals and correlated with executive function scores but not with amyloid load. Hypothesis-generating analyses suggested that aMCI participants with a lower SPR had an increased probability of a positive amyloid positron emission tomography. Future research may explore the potential of this measure to classify aMCI individuals according to their AD biomarker status.
Article
Introduction: Recent genome-wide association studies identified new dementia-associated variants. We assessed the performance of updated polygenic risk scores (PRSs) using these variants in an independent cohort. Methods: We used Cox models and area under the curve (AUC) to validate new PRSs (PRS-83SNP, PRS-SBayesR, and PRS-CS) compared with an older PRS-23SNP in 12,031 initially-healthy participants ≥70 years of age. Dementia was rigorously adjudicated according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. Results: PRS-83SNP, PRS-SBayesR, and PRS-CS were associated with incident dementia, with fully adjusted (including apolipoprotein E [APOE] ε4) hazard ratios per standard deviation (SD) of 1.35 (1.23-1.47), 1.37 (1.25-1.50), and 1.42 (1.30-1.56), respectively. The AUC of a model containing conventional/non-genetic factors and APOE was 74.7%. This was improved to 75.7% (p = 0.007), 76% (p = 0.004), and 76.1% (p = 0.003) with addition of PRS-83SNP, PRS-SBayesR, and PRS-CS, respectively. The PRS-23SNP did not improve AUC (74.7%, p = 0.95). Conclusion: New PRSs for dementia significantly improve risk-prediction performance, but still account for less risk than APOE genotype overall.
Article
Full-text available
Psychometric characteristics of the Alzheimer's Disease Assessment Scale (ADAS) were examined on the basis of data from 440 patients with dementia of the Alzheimer type that were collected before treatment in a multicenter clinical drug trial. Coefficients of internal consistency of above .80 for the cognitive (ADAS-Cog) and the noncognitive section (ADAS-Noncog) indicated a high degree of homogeneity of item contents within the two assessment domains. Test-retest reliability was estimated to be .93, .98, and .96 for ADAS-Cog, ADAS-Noncog, and the total score (ADAS-Total), respectively. Reliably detectable individual changes, which were derived from the reliability estimates, were 7,3, and 8 points for ADAS-Cog, ADAS-Noncog, and ADAS-Total, in that order. Factor analysis and correlations with MMSE, SKT, and NOSGER scores support the validity of the ADAS-Cog and ADAS-Noncog scores with regard to the cognitive and the noncognitive assessment domains. The ADAS summary scores, almost all of the cognitive items, and some of the noncognitive items discriminated significantly between stages of severity of dementia, as classified independently by MMSE and SKT scores.
Article
Full-text available
A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. Item descriptions, administration procedures, and scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28 normal elderly subjects were rated on 40 items. Twenty-one items with significant intraclass correlation coefficients for interrater reliability (range, .650-.989) and significant Spearman rank-order correlation coefficients for test-retest reliability (range, .514-1) constitute the final scale. Subjects with Alzheimer's disease had significantly more cognitive and noncognitive dysfunction than the normal elderly subjects.
Article
Full-text available
This study measured the annual rate of cognitive change in patients with Alzheimer's disease and determined the effects of clinical variables on that rate. It also compared the ability of two cognitive scales to measure change over the entire range of dementia severity. The cognitive subscale of the Alzheimer's Disease Assessment Scale and the Blessed test for information memory and concentration were given to 111 patients with Alzheimer's disease and 72 nondemented elderly comparison subjects at 6-month intervals for up to 90 months. Longitudinal changes in scores on the cognitive subscale were measured with several different methods of data analysis. For the patients with Alzheimer's disease, the annual rate of change in cognitive subscale scores showed a quadratic relationship with dementia severity in which deterioration was slower for mildly and severely demented patients than for patients with moderate dementia. Gender, age at onset, and family history of dementia had no effect on the rate of cognitive deterioration. The comparison group showed a slight improvement in cognitive performance over time. All data analytic methods gave similar results. The cognitive subscale of the Alzheimer's Disease Assessment Scale was more sensitive to change in both mild and severe dementia than was the Blessed test. These results suggest that cognitive deterioration is slow during the early and very late stages of Alzheimer's disease and more rapid during the middle stages. No clinical variables other than degree of cognitive impairment and previous rate of cognitive decline predicted rate of deterioration. These results have implications for treatment trials and attempts to identify subgroups.
Article
The Alzheimer Disease Assessment Scale (ADAS) was administered to 61 patients with dementia of the Alzheimer type (DAT) and 52 elderly controls. The DAT group was subdivided into different severity levels of dementia based on scores from the Mini-Mental State Exam: very mild (greater than or equal to 24), mild (20 to 23), moderate (10 to 19), and severe (0 to 9). The mean scores on the ADAS Cognitive subscale for the four levels of dementia (very mild = 23.1 +/- 7.7, mild = 22.9 +/- 8.9, moderate = 38.6 +/- 9.8, severe = 54.8 +/- 7.6) were statistically different from one another (p less than 0.0001, except very mild vs. mild) and were significantly worse than the scores of the elderly control group (5.5 +/- 2.7, p less than 0.0001, ANOVA). Furthermore, the ADAS Cognitive subscale was highly effective in discriminating individual Alzheimer patients from elderly controls. The ADAS Cognitive score correctly classified 100% of the very mild group, 91% of the entire mild group, and 100% of the moderate and severe groups when a cutoff score of 2 SDs above the control group mean was used. Age and education had only minimal effects on the ADAS Cognitive score. The ADAS is a valuable screening test that only takes 30 min to administer and has utility in both early detection and staging of DAT.
Article
The Alzheimer Disease Assessment Scale (ADAS) was administered to 61 Alzheimer patients, 52 elderly controls, and 80 controls between age 7 and 54 years. The Alzheimer group was categorized into different severity levels of dementia based on MMSE scores: very mild (> or = 24), mild (> or = 20), moderate (10-19), and severe (0-9). All 11 ADAS Cognitive subtest scores for the mild, moderate, and severe dementia groups were statistically worse than the elderly control group. This was also the case for the very mild group, except for Naming, Commands, Constructional Praxis, and Ideational Praxis. In terms of magnitude of effect, memory and spontaneous language items were the earliest indicators on the ADAS, while praxis, commands, and naming items were only sensitive later in the course of the disorder. The best single indicators of progression throughout the severity continuum of dementia (i.e., from normal to severe) were the Orientation subtest, the ADAS Cognitive score, and the ADAS Total score. The ADAS Noncognitive subtests generally did not show the progression with increasing dementia that was evident on the ADAS Cognitive subtest. Differences in educational level had no statistically significant effects on any of the ADAS subtest scores, and age differences were few and small in magnitude. The differential rate of decline of the various ADAS subtests appears to reflect both the changing pattern of cognitive impairments as a function of severity of DAT and also to some extent the psychometric limitations of some of the subtests.
Article
The cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog) is used to monitor disease progression and treatment efficacy in clinical trials of Alzheimer's disease (AD). Using data from a 12-week drug trial, we retrospectively studied the effect of education on ADAS-Cog performance in a group of 444 patients with AD. The effect of education was statistically significant on baseline ADAS-Cog total scores. This effect remained statistically significant after controlling for age, gender, and dementia severity. Education effects were also statistically significant at week 12 for ADAS-Cog total and 10 of 11 subitem scores in 138 AD patients in the placebo arm of the trial. Post hoc analysis showed that non-high school graduates performed worse than those with greater educational levels across a broad range of cognitive domains. Our results, in conjunction with reports linking lower educational level with a higher risk for AD, suggest that educational level of patients be given consideration in the design and interpretation of cognitive tests in AD drug trials.
Article
The cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog) is designed specifically to assess memory, language, and praxis dysfunctions characteristic of Alzheimer's disease (AD). In this report, we use data from 1,648 AD participants in two identical 26-week multicenter drug trials to derive clinical trial population-based norms for ADAS-Cog subtest scores. All 11 ADAS-Cog item scores were sensitive to differences in dementia severity judged either by baseline Mini-Mental State Exam (MMSE) scores or by Global Deterioration Scale (GDS) stage of dementia. Using ADAS-Cog subtest scores alone, 85 percent of GDS 4 subjects and 69 percent of GDS 5 subjects could be classified correctly. In a stepwise discriminant analysis, orientation was the item with the greatest discriminatory power between subjects with GDS 4 and GDS 5 stages of dementia. ADAS-Cog subtest scores also varied by age, gender, educational level, and concurrent use of anti-inflammatory drugs or estrogen (in women). Such normative data may facilitate the selection of appropriate outcome measures to investigate differential treatment effects on specific cognitive domains or in specific AD subpopulations.